Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy

International Journal of Pharmaceutics

Volumn 241, Issue 1, 2002, Pages 1-25

  Dass, Crispin R ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

Cancer; Cationic liposome; Gene therapy; Lipoplex; Nucleic acid

Indexed keywords

DENDRIMER; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FLUCYTOSINE; LIPOSOME; OLIGONUCLEOTIDE; PLASMID DNA; POLYETHYLENEIMINE;

CLINICAL TRIAL; COMPLEX FORMATION; CPG ISLAND; CYTOTOXICITY; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; LIVER TOXICITY; MOLECULAR SIZE; NEPHROTOXICITY; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; LIPID METABOLISM; LIPIDS; LIPOSOMES; NEOPLASMS; TRANSFECTION;

EID: 0037043080     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00194-1     Document Type: Review

References (241)

1. A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity
2. The cell biology of macrophage activation
3. Towards gene therapy for cystic fibrosis: A clinical progress report
4. Targeted gene delivery: A two-pronged approach
5. Cationic lipid-based delivery system for systemic cancer gene therapy
6. Optimization of nonviral gene transfer of vascular smooth mucle cells in vitro and in vivo
7. Structural and functional analysis of cationic transfection lipids: The hydrophobic domain
8. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration
9. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
10. The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice
11. Cationic lipid-mediated gene delivery to murine lung: Correlation of lipid hydration with in vivo transfection activity
12. Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid
13. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
14. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases
15. Tumor angiogenesis and interstitial hypertension
16. Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid
17. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs
18. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs
19. Activation of host tumoral responses by cationic lipid/DNA complexes
20. Transfection of nasal mucosa with a normal α1-antitrypsin gene in α1-antitrypsin-deficient subjects: Comparison with protein therapy
21. 2+ and von Willebrand factor release in human endothelial cells
22. Growth inhibition of experimental glioma by human interferon-β superinduced by cationic liposomes entrapping polyinosilic:polycytidilic acid
23. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vivo study relevant to bone marrow purging
24. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits
25. Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol
26. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
27. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter
28. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
29. Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
30. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity
31. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
32. Gene transfer therapy of Gaucher disease
33. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene
34. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum
35. Restoration by intratracheal gene transfer of bicarbonate secretion in cystic fibrosis mouse gallbladder
36. Use of perfluorocarbon (Fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: Implications for nebulized delivery of plasmids
37. Vehicles for oligonucleotide delivery: Therapeutic applicability against tumors
38. Lipoplexes and tumors
39. Microsphere-mediated targeted gene therapy of solid tumors
40. Limitation of lipoplexes for gene therapy of solid tumors
41. Tumor gene-targeting using microspheres: Cell culture and in vivo studies
42. Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis
43. Delivery of lipoplexes for genotherapy of solid tumors: Role of vascular endothelial cells
44. Liposomes containing cationic dimethyl dioctadecyl ammonium bromide (DDAB): Formulation, quality control and lipofection efficiency
45. In vitro evaluation of ion-exchange microspheres as carriers of plasmid DNA
46. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation
47. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model
48. Cationic phosphonolipids as nonviral vectors: In vitro and in vivo applications
49. Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases
50. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
51. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12
52. Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo
53. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery
54. TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo
55. Cationic lipid-mediated gene transfer: Effect of serum on cellular uptake and intracellular fate of lipoployamine/DNA complexes
56. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity
57. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
58. Optimization of cationic lipid-mediated gene transfer to airway epithelia
59. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure
60. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
61. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain carrier
62. Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma
63. Immunomodulatory activity of some amphiphilic compounds
64. Role of vascular endothelial growth factor in the regulation of angiogenesis
65. Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity
66. Anti-inflammatory activity of cationic lipids
67. Toxicity and immunomodulatory activity of some liposomal vectors formulated with cationic lipids toward immune effector cells
68. Major limitations in the use of cationic liposomes for DNA delivery
69. Cation substitution in cationic phosphonolipids: A new concept to improve transfection activity and decrease cellular toxicity
70. Systemic administration of cationic phosphonolipid/DNA complexes and the relationship between formulation and lung transfection efficiency
71. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes
72. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
73. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular netwroks
74. Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency
75. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
76. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy
77. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
78. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer
79. Size dependent liposome degradation in blood: In vivo/in vitro correlation by kinetic modeling
80. + hematopoietic cells
81. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter
82. Synthesis of novel cationic lipids: Effect of structural modification on the efficiency of gene transfer
83. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
84. In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex
85. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
86. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A Phase I clinical trial
87. Liposome-mediated gene transfer into human basal cell carcinoma
88. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes
89. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes
90. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
91. Characteristics and biodistribution of cationic liposomes, and their DNA complexes
92. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of antisense phosphorothioate oligonucleotides
93. Amphiphilic detergents inhibit production of IgG and IgM by human peripheral blood mononuclear cells
94. Delivery of molecular medicine to solid tumors: Lessons from in vivo imaging of gene expression and function
95. Attenuation of the acute-phase response in thermally injured rats by cholesterol-containing cationic liposomes used as a delivery system for gene therapy
96. The effect of particle size and charge on clearance on the clearance rates of liposomes and liposome encapsulated drugs
97. Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA
98. Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol derivative
99. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size
100. Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells
101. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal models
102. Comparison of cell proliferation and toxicity assays using two cationic liposomes
103. Gene transfer into subcultured endometrial cells using lipofection
104. Liposomes and lipidic particles in gene therapy
105. Percutaneous arterial gene transfer in a rabbit model
106. Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression
107. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung
108. Enhancement of adenoviral transduction with polycationic liposomes in vivo
109. Expression of exogenous DNA in rat liver cells after liposome-mediated transfection in vivo
110. Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line
111. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice
112. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles
113. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors
114. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog
115. The significance of heterogeneous tumor cell clumps in the metastatic process
116. Fate of cationic liposomes and their complex with oligonucleotide in vivo
117. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes
118. Development of non-viral vectors for systemic gene delivery
119. Cationic liposome-mediated intravenous gene delivery
120. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes
121. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration
122. Systemic gene delivery expands the repertoire of effective antiangiogenic agents
123. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes
124. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo
125. Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo
126. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration
127. Toxicology of non-viral gene transfer
128. Hypertension in unilaterally nephrectomized rats induced by single-kidney transfection with angiotensinogen cDNA
129. In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery
130. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
131. Multiple systemic expression of human interferon-β in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex
132. Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA
133. Effect of human interferon-β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells
134. Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus
135. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice
136. Technology evaluation: Gene therapy (IL-2), Valentis Inc.
137. Cationic lipid-mediated transfection of cells in culture requires mitotic activity
138. Membrane perturbation and the mechanism of lipid-mediated transfer of DNA into cells
139. Immune stimulation by a CpG-containing oligodeoxynucleotide in enhanced when encapsulated and delivered in lipid particles
140. Catheter-mediated pulmonary vascular gene transfer and expression
141. Targeting solid tumors: Challenges, disappointments, and opportunities
142. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes
143. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization
144. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biological activity, and lack of toxicity in humans
145. Site-specific gene expression in vivo by direct gene transfer into the arterial wall
146. Transduction of a foreign histocompatibility gene into the arterial wall induced vasculitis
147. Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo
148. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma
149. Is control of distribution of liposomes between tumors and bone marrow possible?
150. Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection
151. Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse
152. Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma
153. A new temperature sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model
154. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation
155. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo
156. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer
157. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis
158. Evaluation of cationic liposome suitable for gene transfer into pregnant animals
159. 33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionuclide approach
160. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzmann reaction
161. Gene transfer in skeletal muscle by systemic injection of DODAC lipopolyplexes
162. Plasmid DNA gene therapy: Studies with the human interleukin-12 gene in tumor cells in vitro and in the murine B16 model in vivo
163. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates
164. Gene therapy of HNSCC with liposomal mediated h-IL-2 plasmids - phase I-study
165. Liposome-mediated DNA vaccination: The effect of vesicle composition
166. Liposome-mediated gene transfer into human vascular smooth muscle cells
167. Efficiency and toxicity of liposome-mediated gene transfer to corneal epithelial cells
168. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
169. Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression
170. Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms
171. Structural basis of DOTMA for its high intravenous transfection activity in mouse
172. Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization
173. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis
174. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies
175. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice
176. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: The role of the neutral helper lipid
177. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy
178. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
179. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity
180. Direct gene transfer into the rat pancreas using DNA-liposomes
181. The role of CpG motifs in immunostimulation and gene therapy
182. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung
183. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures
184. Interaction of positively-charged liposomes with blood: Implications for their application in vivo
185. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents
186. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model
187. Characterization and in vivo testing of a heterogeneous cationic lipid-DNA formulation
188. Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer
189. Factors influencing the drug sensitization of human tumor cells for in situ lipofection
190. Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA
191. Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration
192. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmids DNA
193. Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: A phase I trial of safety and efficacy in the nasal airway
194. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
195. Importance of liposome complexing volume in transfection optimization
196. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo
197. Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice
198. Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma
199. The role of CXC chemokines as regulators of angiogenesis
200. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1
201. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors
202. Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings
203. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: Growth inhibition of tumors and lack of localization in normal tissues
204. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation
205. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
206. Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro
207. Synthesis of a single-tailed cationic lipid and investigation of its transfection
208. Assessment of ocular irritability of liposome preparations
209. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice
210. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice
211. Lung-specific direct in vivo gene transfer with recombinant plasmid DNA
212. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo
213. Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection
214. Mechanism of lipoplex gene delivery in mouse lung: Binding and internalization of fluorescent lipid and DNA components
215. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery
216. A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection
217. Immunoliposome-mediated gene transfer into cultured myotubes
218. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
219. LPD lipoployplex initiates a potent cytokine response and inhibits tumor growth
220. Cationic lipid binding to DNA: Characterization of complex formation
221. β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: A cautionary tale
222. Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy
223. In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes
224. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity
225. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts
226. Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: Cytocidal effect on glioma transplanted into nude mouse brain
227. Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethyleneimine
228. Intracellular hyperthermia for cancer using magnetite cationic liposomes: An in vivo study
229. Time-dependent maturation of cationic liposome-DNA complex for serum resistance
230. Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes
231. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes
232. Reduced inflammatory response to plasmid vectors by elimination and inhibition of immunostimulatory CpG motifs
233. DNA immunization: Effects of vehicle and route of administration on the induction of protective antiviral immunity
234. Cellular and molecular barriers to gene transfer by a cationic lipid
235. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: Improvement of cell sensitization to ganciclovir
236. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation
237. Systemic gene expression after intravenous DNA delivery into adult mice
238. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy
239. Effect of vesicle size and lipid composition on the in vivo tumor selectively and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes
240. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery